JPRN-UMIN000029836已完成2 期
A multicenter study of adjuvant nab-paclitaxel followed by FEC for early breast cancer - A study of adjuvant nab-paclitaxel followed by FEC for early breast cancer
Kyushu Breast Cancer Study Group (KBC-SG)0 个研究点目标入组 60 人开始时间: 2017年11月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients with a history of hypersensitivity to paclitaxel and/or albumin 2) Metachronous bilateral breast cancer 3) Inflammatory breast cancer 4) Active double cancer 5) Other severe complications such as infectious diseases, diarrhea, intestinal palsy, intestinal obstruction, uncontrolled diabetes mellitus, uncontrolled angina, myocardial infarction within 6 months and heart failure 6) Pregnant and nursing female 7) Patients with pulmonary fibrosis or interstitial pneumonia 8) Sever bone marrow suppression, renal dysfunction, liver dysfunction 9) History of hypersensitivity reaction 10)Others
研究者
相似试验
已完成
2 期
A study of neoadjuvant nab-paclitaxel followed by FEC for luminal B-like (HER2-negative) and triple-negative breast canceruminal B-like (HER2-negative) or triple-negative operable breast cancerJPRN-UMIN000017675Kyushu Breast Cancer Study Group (KBC-SG)94
已完成
2 期
Phase II study of neoadjuvant nab-paclitaxel and trastuzumab for ER negative and HER2 positive breast cancerER negative and HER2 positive breast cancerJPRN-UMIN000019616Osaka Medical College18
招募中
不适用
Feasibility study of adjuvant nab-paclitaxel in breast cancerbreast cancerJPRN-UMIN000007725Graduate school of medicine,Chiba University55
已完成
2 期
Pilot study of low-dose Nab-paclitaxel as adjuvant chemotherapy in patients with breast cancerBreast CancerJPRN-UMIN000012047Kitasato University Kitasato Institute Hospital20
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22